Probiotics Rosacea Meta-analysis: What the Evidence Says

Quick Answer

Probiotics Rosacea Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 narrative review, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• : TLR2, Toll-like receptor 2; KLK5, kallikrein-related peptidase 5; hCAP18, human cationic antimicrobial protein 18; LL-37, cathelicidin-derived peptide; NF-κB, nuclear factor κB; NLRP3, NOD-like receptor thermal protein domain-associated protein 3; JAK/STAT, Janus kinase/signal transducer and activator of transcription; mTORC1, mammalian target of rapamycin complex 1. [Shi Lei (2026); evidence level 3]
• • Moreover, emerging evidence implicates the gut-skin axis, as dysbiosis in the gut microbiota may contribute to the pathogenesis of rosacea through immune modulation, opening avenues for probiotic interventions but failing to address direct fungal involvement. [Tang Xiaobin (2026); evidence level 4]
• To address this, our study provides the first comprehensive dual-kingdom analysis of rosacea-associated microbiome alterations by simultaneously examining bacterial (via 16S rRNA sequencing) and fungal (via ITS sequencing) communities in facial samples from patients with rosacea and healthy controls. [Tang Xiaobin (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For probiotics rosacea meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Shi Lei (2026). Neurohormonal-Immune Dysregulation in Rosacea: Emerging Perspectives from the Skin-Gut-Brain Axis. DOI: 10.2147/DDDT.S608151. PMCID: PMC13282955. PMID: 42325915. License: https://creativecommons.org/licenses/by-nc/4.0/ https://www.dovepress.com/terms.php http://creativecommons.org/licens.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13282955/
• Tang Xiaobin (2026). A pilot study investigating the bacterial and fungal community shifts in facial skin in rosacea. DOI: 10.1177/03000605261454625. PMCID: PMC13254424. PMID: 42270571. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13254424/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.